Unmatched Precision in Radiation Therapy

Proton therapy can target head and neck tumors with unmatched precision while minimizing irradiation dose to the eyes, optic nerves, vocal cords, salivary glands, mouth, brain, jaw, and other nearby organs and structures. There is less risk of side effects like blindness, hearing loss, dry mouth, trouble swallowing, loss of taste or voice, and endocrine disorders.

Head and Neck Cancers We Treat Include
  • Tonsil, base-of-tongue cancer, oral cavity, and other oropharynx cancers
  • Nasopharynx cancers
  • Nasal cavity and paranasal sinus cancers
  • Throat cancers (nasopharyngeal/oropharyngeal)
  • Hypopharynx cancers
  • Tracheal cancers
  • Lacrimal gland cancers
  • Esthesioneuroblastomas
  • Salivary gland cancers
  • Skin with perineural invasion or lymph node metastases
  • Tumors of the eye/orbit
  • Thyroid cancers
  • Recurrent head and neck tumors

Lancet Phase III Study Shows Proton Therapy Significantly Improves Survival and Reduces Toxicity in Head and Neck Cancers

Results from a major multi-institutional Phase III clinical trial published in The Lancet in December 2025 show that proton therapy improved overall survival while reducing side effects and improving quality of life for patients with oropharyngeal head and neck cancers, compared with traditional radiation therapy.

FAQs icon

Head and Neck Tumors Proton Therapy FAQs

Read our frequently asked questions about proton therapy for head and neck tumors.

Clinical trials icon

Clinical Trials for Head and Neck Cancers

Learn about the available clinical trials for head and neck tumors at the New York Proton Center.

Latest Articles